GENERAL18 Sept 2026
FSSAI initiates legal action against Nestle India over infant products
India's food regulator, the Food Safety and Standards Authority of India (FSSAI), has begun legal action against Nestle India over three infant nutrition products. It examined NAN Excella Pro Stage 1, Lactogen Pro 1 and a follow-up formula, flagging promotional claims and a sub-standard biotin sample. Three adjudication cases are now filed. If you sell or promote infant food, check your product claims and online listings.
Key Statutory Highlights
- FSSAI examined NAN Excella Pro Stage 1, Lactogen Pro 1 and a follow-up formula along with their promotional material on e-commerce platforms.
- The regulator flagged claims about 5HMOs and Whey Protein, saying these breach rules that bar promotion of infant foods.
- A follow-up formula sample was found sub-standard for Biotin content, and a referral laboratory also found it non-conforming.
Actionable Advice for Taxpayers / Founders:If you sell or market infant nutrition products, review your label claims and e-commerce listings for anything that could read as promotion, and keep supporting documents ready in case FSSAI seeks clarification.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: